OverviewChartNewsTraderScreen

Morgan Stanley Call 111 AMD 20.09.../  DE000ME2QKN3  /

Stuttgart
5/22/2024  1:36:50 PM Chg.+0.04 Bid3:16:28 PM Ask3:16:28 PM Underlying Strike price Expiration date Option type
8.77EUR +0.46% 8.77
Bid Size: 2,000		 8.80
Ask Size: 2,000		 Advanced Micro Devic... 111.00 USD 9/20/2024 Call
GlobeNewswire 5/21 AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...
GlobeNewswire 5/21 AMD Expands EPYC CPU Portfolio to Bring New Levels of Performance and Value for Small and Medium Bus...
GlobeNewswire 5/21 Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire 5/21 YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)
TeleTrader 5/20 Microsoft will 'soon welcome' AMD, Intel chips
GlobeNewswire 5/20 Broadcom Revolutionizes AI Networking Landscape with High-Performance 400G RoCE/RDMA Ethernet NICs
Newsfile Corp 5/16 FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization
GlobeNewswire 5/15 Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...
GlobeNewswire 5/14 AMD Announces Upcoming Events for the Financial Community
GlobeNewswire 5/14 Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...
GlobeNewswire 5/14 Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/13 Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...
GlobeNewswire 5/13 AMD Remains the Partner of Choice for World’s Fastest and Most Efficient High Performance Computing ...
GlobeNewswire 5/9 Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/9 Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlight...
GlobeNewswire 5/9 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire 5/8 Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progress...
GlobeNewswire 5/8 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 5/8 AMD Receives IEEE 2024 Corporate Innovation Award for Leadership in Chiplet Design for High-Performa...
GlobeNewswire 5/8 Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
GlobeNewswire 5/8 EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporat...
GlobeNewswire 5/7 Ocular Therapeutix™ Reports First Quarter 2024 Results
GlobeNewswire 5/7 Optiver Chooses AMD Enterprise Portfolio to Power its Data Center Modernization, Enabling New Era of...
GlobeNewswire 5/7 Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
GlobeNewswire 5/7 Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)